T-Cell Immunodeficiencies
T-cell deficiencies include (a)
DiGeorge syndrome, (b) chronic
mucocutaneous candidiasis, (c)
transient hypogammaglobu-linemia of infancy, and (d) common, variable, unclassified immunodeficiency.
The DiGeorge syndrome or thymic aplasia is a classic example of a
pure T-cell deficiency. Although the DiGeorge syndrome is a congenital
immunodeficiency, it is not hereditarily transmitted. The condition is believed
to be caused by an intrauterine infection prior to the eighth week of life,
possibly of viral etiol-ogy. It is associated with microdeletions of
chromosomal region 22q11. From the immunological point of view, it results due
to defective embryogenesis of the third and fourth pharyngeal clefts at 6–8
weeks of fetal life, leading to deficient development of the thymus and
parathyroids.
Tetany and hypocalcemia, both characteristics of
hypopara-thyroidism, are observed in DiGeorge syndrome in addition to the defects
in T-cell immunity. Peripheral lymphoid tissues exhibit a deficiency of
lymphocytes in thymic-dependent areas. A defect in delayed-type
hypersensitivity is demonstrated by the failure of affected patients to develop
positive skin tests to commonly employed antigens, such as candidin or
streptoki-nase and the inability to develop an allograft response. There is
also minimal or absent in vitro
responsiveness to T-cell antigens or mitogens. Defective cell-mediated immunity
may increase susceptibility of the patient to opportunistic infections and
render the individual vulnerable to a graft-versus-host reaction in blood
transfusion recipients.
However, the B or bursa equivalent-dependent areas, such as
lymphoid follicles, show normal numbers of B cells and plasma cells in patients
with DiGeorge syndrome. Serum immuno-globulin levels are within normal limits,
and there is a normal immune response following immunization with commonly
employed immunogens. Considerable success in treatment of DiGeorge syndrome has
been achieved with fetal thymic trans-plants and by the passive administration
of thymic humoral factors.
Some patients with chronic infection of skin and mucosa with Candida albicans have exhibited a
selective deficiency of cell-mediated immunity. Affected individuals develop
severe and widespread forms of candidal infections. Skin tests with Candida antigens and in vitro lymphocyte proliferation
responses to C. albicans reveal a
selective lack of reactivity. T-lymphocyte functions are normal when tested
with other antigens and mitogens. The humoral response to C. albicans is also normal. Symptomatic therapy with antimycotic
agents is often unsuccessful.
This condition is characterized by the hypogammaglobu-linemia in
infants that occurs due to progressive catabolism of maternal IgG during the
second and third months of life. This condition may persist until 2–3 years of
age and become progressively more accentuated. In most cases, a deficiency of
helper T-cell function appears to be responsible for the delay in
immunoglobulin synthesis.
The diagnostic hallmark for this disease is low-for-age
circu-lating immunoglobulin levels. Peripheral blood B lymphocytes are usually
normal. Intravenous gamma globulin is indicated until the child’s
immunoglobulin levels normalize. With time, most children develop normal immune
function.
This condition, also known as late onset hypogammaglobu-linemia,
includes a large number of cases of primary immuno-deficiency with
heterogeneous presentations. These conditions show a variable age of onset and
patterns of inheritance, whose clinical picture is similar to that of XLA, but
with a less severe course of clinical manifestations. T-cell function appears
to be deficient in most cases, with abnormally low proliferative responses to
T-cell mitogens.
Sinusitis and bacterial pneumonia are the predomi-nant infections
in patients with common, variable, unclas-sified immunodeficiency. Intestinal
giardiasis is common. Opportunistic infections caused by Pneumocystis jiroveci, mycobacteria, viruses, and other fungi are
also more frequent in these patients. Treatment usually involves administration
of intravenous gamma globulin.
Related Topics
Privacy Policy, Terms and Conditions, DMCA Policy and Compliant
Copyright © 2018-2023 BrainKart.com; All Rights Reserved. Developed by Therithal info, Chennai.